Oral Cancer Test Gets European Conformity (CE) Mark
2016-05-06
Vigilant Biosciences has received the European Conformity (CE) mark for its OncAlert Oral Cancer RAPID Test, enabling the company to market the product in the
CE Mark
Cancer Detection Tool Earns CE Mark
2015-11-18
The OncAlert Oral Cancer CD44/Total Protein LAB Test from Vigilant Biosciences now has the CE Mark, which means it has been approved for distribution and
